ACMR to Sponsor and Participate in the 2011 CNS Summit
ATLANTA- Oct. 7, 2011- The Atlanta Center for Medical Research is proud to announce its participation in the 2011 CNS Summit as both a Main Sponsor and Participating Company.
Taking place November 17 through November 20, 2011 at the Boca Raton Resort & Club in Boca, Florida, the CNS Summit focuses on improving the success of researchers by bringing new treatments to patients suffering from CNS disorders.
“The CNS Summit provides an excellent opportunity to participate in the future of cutting edge CNS pharmaceutical research,” stated Maria Atella, the Business Development and Rater Manager for the Atlanta Center for Medical Research, “We look forward to exploring new models for drug development that assist the site in implementing exciting and sophisticated clinical trials in CNS research. ACMR’S 30 years of experience will provide an added dimension to the future of CNS drug discovery.”
This year’s meeting will bring together CNS drug developers and the medical research community from around the world. The 2011 CNS Summit hopes to produce concrete results that will shape the future of CNS drug development for the years to come.
“A meeting bringing together these groups will help overall in production of new and improved CNS medications,” said Eric Riesenberg, Director of Operations for the Atlanta Center for Medical Research.
For more information about the CNS Summit, please visit their website at http://www.cnssummit.org/
###
About ACMR
Since 1980, Atlanta Center for Medical Research (ACMR) has been a leader in clinical research. Conducting both inpatient & outpatient clinical trial, ACMR provides professional, conscientious research services that are pivotal in the advancement and treatment of illnesses of the central nervous system and other therapeutic areas. Our dedicated and experienced research team conducts clinical trials with compassion and respect for our research participants. We deliver timely and accurate results that ultimately improve the lives of people through the development of safe and effective drug therapies.
For more information please call (404) 881-5800 or visit our volunteer for a study page.
